Status: Not yet recruiting
A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes
This is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.
Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Dren BioUpdated: Jul 24, 2026Locations: 10
Eligibility criteria
Age ≥ 18 years old [+12]
Diagnosis of Fanconi anemia, dyskeratosis congenita, or other congenital BMF syn... [+17]